Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein–ACE2 interaction

被引：0
|
作者：
ChangDong Lin
Yue Li
YueBin Zhang
ZhaoYuan Liu
Xia Mu
Chenjian Gu
Jing Liu
Yutang Li
GuoHui Li
JianFeng Chen
机构：
[1] University of Chinese Academy of Sciences,State Key Laboratory of Cell Biology, Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences
[2] Chinese Academy of Sciences,State Key Laboratory of Molecular Reaction Dynamics, Dalian Institute of Chemical Physics
[3] Fudan University,Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Department of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Shanghai Medical College
[4] BSL-3 laboratory of Fudan University,School of Life Science, Hangzhou Institute for Advanced Study
[5] School of Basic Medical Sciences,undefined
[6] Shanghai Medical College,undefined
[7] Fudan University,undefined
[8] University of Chinese Academy of Sciences,undefined
来源：
Signal Transduction and Targeted Therapy | / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] ROLE OF CHANGES IN SARS-COV-2 SPIKE PROTEIN IN THE INTERACTION WITH THE HUMAN ACE2 RECEPTOR: AN IN SILICO ANALYSIS
    Ortega, Joseph Thomas
    Serrano, Maria Luisa
    Pujol, Flor Helene
    Rangel, Hector Rafael
    EXCLI JOURNAL, 2020, 19 : 410 - 417
  • [42] ANALYZING THE INTERACTION OF HUMAN ACE2 AND RBD OF SPIKE PROTEIN OF SARS-COV-2 IN PERSPECTIVE OF OMICRON VARIANT
    Samanta, Arijit
    Alam, Syed Sahajada Mahafujul
    Ali, Safdar
    Hoque, Mehboob
    EXCLI JOURNAL, 2022, 21 : 610 - 620
  • [43] Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2)
    Xiang, Yusen
    Wang, Mengge
    Chen, Hongzhuan
    Chen, Lili
    BIOCHEMICAL PHARMACOLOGY, 2021, 192
  • [44] Identification and characterization of a monoclonal antibody blocking the SARS-CoV-2 spike protein-ACE2 interaction
    Yuan, MengYa
    Wan, YaoYing
    Liu, Cui
    Li, Yue
    Liu, ZhaoYuan
    Lin, ChangDong
    Chen, JianFeng
    CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (06) : 1562 - 1564
  • [45] Disulfiram blocked cell entry of SARS-CoV-2 via inhibiting the interaction of spike protein and ACE2
    Chen, Hsiao-Fan
    Hsueh, Po-Ren
    Liu, Yen-Yi
    Chen, Yeh
    Chang, Sui-Yuan
    Wang, Wei-Jan
    Wu, Chen-Shiou
    Tsai, Ya-Min
    Liu, Yu-Shu
    Su, Wen-Chi
    Chou, Yu-Chi
    Hung, Mien-Chie
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (07): : 3333 - +
  • [46] Mutants of human ACE2 differentially promote SARS-CoV and SARS-CoV-2 spike mediated infection
    Shukla, Nidhi
    Roelle, Sarah M.
    Suzart, Vinicius G.
    Bruchez, Anna M.
    Matreyek, Kenneth A.
    PLOS PATHOGENS, 2021, 17 (07)
  • [47] Targeting SARS-CoV-2 by synthetic dual-acting thiol compounds that inhibit Spike/ACE2 interaction and viral protein production
    Fraternale, Alessandra
    De Angelis, Marta
    De Santis, Riccardo
    Amatore, Donatella
    Masini, Sofia
    Monittola, Francesca
    Menotta, Michele
    Biancucci, Federica
    Bartoccini, Francesca
    Retini, Michele
    Fiori, Valentina
    Fioravanti, Raoul
    Magurano, Fabio
    Chiarantini, Laura
    Lista, Florigio
    Piersanti, Giovanni
    Palamara, Anna T.
    Nencioni, Lucia
    Magnani, Mauro
    Crinelli, Rita
    FASEB JOURNAL, 2023, 37 (02):
  • [48] Identification of potential plant bioactive as SARS-CoV-2 Spike protein and human ACE2 fusion inhibitors
    Singh, Rahul
    Bhardwaj, Vijay Kumar
    Sharma, Jatin
    Kumar, Dinesh
    Purohit, Rituraj
    COMPUTERS IN BIOLOGY AND MEDICINE, 2021, 136
  • [49] Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
    Huo, Jiangdong
    Le Bas, Audrey
    Ruza, Reinis R.
    Duyvesteyn, Helen M. E.
    Mikolajek, Halina
    Malinauskas, Tomas
    Tan, Tiong Kit
    Rijal, Pramila
    Dumoux, Maud
    Ward, Philip N.
    Ren, Jingshan
    Zhou, Daming
    Harrison, Peter J.
    Weckener, Miriam
    Clare, Daniel K.
    Vogirala, Vinod K.
    Radecke, Julika
    Moynie, Lucile
    Zhao, Yuguang
    Gilbert-Jaramillo, Javier
    Knight, Michael L.
    Tree, Julia A.
    Buttigieg, Karen R.
    Coombes, Naomi
    Elmore, Michael J.
    Carroll, Miles W.
    Carrique, Loic
    Shah, Pranav N. M.
    James, William
    Townsend, Alain R.
    Stuart, David, I
    Owens, Raymond J.
    Naismith, James H.
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2020, 27 (09) : 846 - +
  • [50] Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
    Jiandong Huo
    Audrey Le Bas
    Reinis R. Ruza
    Helen M. E. Duyvesteyn
    Halina Mikolajek
    Tomas Malinauskas
    Tiong Kit Tan
    Pramila Rijal
    Maud Dumoux
    Philip N. Ward
    Jingshan Ren
    Daming Zhou
    Peter J. Harrison
    Miriam Weckener
    Daniel K. Clare
    Vinod K. Vogirala
    Julika Radecke
    Lucile Moynié
    Yuguang Zhao
    Javier Gilbert-Jaramillo
    Michael L. Knight
    Julia A. Tree
    Karen R. Buttigieg
    Naomi Coombes
    Michael J. Elmore
    Miles W. Carroll
    Loic Carrique
    Pranav N. M. Shah
    William James
    Alain R. Townsend
    David I. Stuart
    Raymond J. Owens
    James H. Naismith
    Nature Structural & Molecular Biology, 2020, 27 : 846 - 854
12345